Assessing the order of critical alterations in prostate cancer development and progression by IHC: further evidence that PTEN loss occurs subsequent to ERG gene fusion

Antibody-Based Detection of ERG Rearrangement-Positive Prostate Cancer

(2015) Kyung Park et al.   NEOPLASIA

A novel four-color fluorescence in situ hybridization assay for the detection of TMPRSS2 and ERG rearrangements in prostate cancer

(2013) Xiaoyu Qu et al.   Cancer Genetics

Novel, gross chromosomal alterations involving PTEN cooperate with allelic loss in prostate cancer

(2012) Alison H M Reid et al.   MODERN PATHOLOGY

PTEN losses exhibit heterogeneity in multifocal prostatic adenocarcinoma and are associated with higher Gleason grade

(2012) Maisa Yoshimoto et al.   MODERN PATHOLOGY

Clonal evolution in cancer

(2012) Mel Greaves et al.   NATURE

Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing

(2012) Li Ding et al.   NATURE

Clonal evolution of acute leukemia genomes

(2012) M Jan et al.   ONCOGENE

Immunohistochemistry for ERG Expression as a Surrogate for TMPRSS2-ERG Fusion Detection in Prostatic Adenocarcinomas

(2011) Alcides Chaux et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Mosaic Amplification of Multiple Receptor Tyrosine Kinase Genes in Glioblastoma

(2011) Matija Snuderl et al.   CANCER CELL

Hallmarks of Cancer: The Next Generation

(2011) Douglas Hanahan et al.   CELL

PTEN Protein Loss by Immunostaining: Analytic Validation and Prognostic Indicator for a High Risk Surgical Cohort of Prostate Cancer Patients

(2011) T. L. Lotan et al.   CLINICAL CANCER RESEARCH

PTEN genomic deletions that characterize aggressive prostate cancer originate close to segmental duplications

(2011) Maisa Yoshimoto et al.   GENES CHROMOSOMES & CANCER

Antibody EPR3864 is specific for ERG genomic fusions in prostate cancer: implications for pathological practice

(2011) Geert JLH van Leenders et al.   MODERN PATHOLOGY

ERG gene rearrangements are common in prostatic small cell carcinomas

(2011) Tamara L Lotan et al.   MODERN PATHOLOGY

Increased gene copy number of ERG on chromosome 21 but not TMPRSS2–ERG fusion predicts outcome in prostatic adenocarcinomas

(2011) Antoun Toubaji et al.   MODERN PATHOLOGY

PTEN genomic deletion is an early event associated with ERG gene rearrangements in prostate cancer

(2010) Tarek A. Bismar et al.   BJU INTERNATIONAL

Molecular characterisation of ERG, ETV1 and PTEN gene loci identifies patients at low and high risk of death from prostate cancer

(2010) A H M Reid et al.   BRITISH JOURNAL OF CANCER

Single Focus Prostate Cancer: Pathological Features and ERG Fusion Status

(2010) Sara M. Falzarano et al.   JOURNAL OF UROLOGY

ERG oncoprotein expression in prostate cancer: clonal progression of ERG-positive tumor cells and potential for ERG-based stratification

(2010) B Furusato et al.   PROSTATE CANCER AND PROSTATIC DISEASES

A Robust Immunohistochemical Assay for Detecting PTEN Expression in Human Tumors

(2010) Zaina Sangale et al.   APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY

TMPRSS2–ERG gene fusion status in minute (minimal) prostatic adenocarcinoma

(2009) Roula Albadine et al.   MODERN PATHOLOGY

Fluorescence in situ hybridization study shows association of PTEN deletion with ERG rearrangement during prostate cancer progression

(2009) Bo Han et al.   MODERN PATHOLOGY

ETS rearrangements and prostate cancer initiation

(2009) Brett S. Carver et al.   NATURE

Tomlins et al. reply

(2009) Scott A. Tomlins et al.   NATURE

Copy number analysis indicates monoclonal origin of lethal metastatic prostate cancer

(2009) Wennuan Liu et al.   NATURE MEDICINE

Cytopathology

(2008)   MODERN PATHOLOGY